These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12838959)

  • 1. American Society of Hematology--44th Annual Meeting and Exposition. Drug highlights I. 6-10 December 2002, Philadelphia, PA, USA.
    Adekale M
    IDrugs; 2003 Jan; 6(1):1-3. PubMed ID: 12838959
    [No Abstract]   [Full Text] [Related]  

  • 2. American Society of Hematology--44th Annual Meeting and Exposition. Drug highlights II. 6-10 December 2002, Philadelphia, PA, USA.
    Adekale M
    IDrugs; 2003 Jan; 6(1):4-5. PubMed ID: 12838960
    [No Abstract]   [Full Text] [Related]  

  • 3. American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA.
    Erlich R; Durrance A
    IDrugs; 2003 Jul; 6(7):628-30. PubMed ID: 12906005
    [No Abstract]   [Full Text] [Related]  

  • 4. American Society of Hematology--48th Annual Meeting and Exposition. The Factor Xa target, and disorders of platelet number and function. 9-12 December 2006 Orlando, FL, USA.
    Tear S
    IDrugs; 2007 Feb; 10(2):81-3. PubMed ID: 17285453
    [No Abstract]   [Full Text] [Related]  

  • 5. Abstracts of the American Society of Hematology 44th annual meeting. December 6-10, 2002. Philadelphia, Pennsylvania, USA.
    Blood; 2002 Nov; 100(11 Pt 1):1a-1016a. PubMed ID: 12448415
    [No Abstract]   [Full Text] [Related]  

  • 6. Abstracts of the American Society of Hematology 44th annual meeting. December 6-10, 2002. Philadelphia, Pennsylvania, USA.
    Blood; 2002 Nov; 100(11 Pt 2):1b-504b. PubMed ID: 12448414
    [No Abstract]   [Full Text] [Related]  

  • 7. American Society of Hematology--48th Annual Meeting and Exposition. Therapeutic approaches for hematological cancers. 9-12 December 2006 Orlando, FL, USA.
    Tear S
    IDrugs; 2007 Feb; 10(2):84-6. PubMed ID: 17285454
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteasome inhibitors in the treatment of cancer.
    Golab J
    Drug Discov Today; 2003 Jul; 8(13):575. PubMed ID: 12850331
    [No Abstract]   [Full Text] [Related]  

  • 9. American Society of Hematology--49th Annual Meeting and Exposition. Part 2. 7-11 December 2007, Atlanta, GA, USA.
    Murch L
    IDrugs; 2008 Feb; 11(2):73-5. PubMed ID: 18240085
    [No Abstract]   [Full Text] [Related]  

  • 10. American Society of Hematology--49th Annual Meeting and Exposition. Part 3. 7-11 December 2007, Atlanta, GA, USA.
    Veryard C
    IDrugs; 2008 Feb; 11(2):76-8. PubMed ID: 18240086
    [No Abstract]   [Full Text] [Related]  

  • 11. American Society of Hematology--49th Annual Meeting and Exposition. Part 1. 7-11 December 2007, Atlanta, GA, USA.
    Murch L; Veryard C
    IDrugs; 2008 Feb; 11(2):71-2. PubMed ID: 18240084
    [No Abstract]   [Full Text] [Related]  

  • 12. American Society of Hematology 55th Annual Meeting and Exposition (December 7-13, 2013 - New Orleans, Louisiana, USA).
    McNamara Y; Lam S; Stringer M
    Drugs Today (Barc); 2013 Dec; 49(12):823-8. PubMed ID: 24524101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Chemical Society--227th Annual Meeting. New disclosures. 28 March - 1 April 2004, Anaheim, CA, USA.
    Garvey R; Veryard C
    IDrugs; 2004 May; 7(5):423-5. PubMed ID: 15154098
    [No Abstract]   [Full Text] [Related]  

  • 14. Assays for proteasome inhibition.
    Elliott PJ; Soucy TA; Pien CS; Adams J; Lightcap ES
    Methods Mol Med; 2003; 85():163-72. PubMed ID: 12710207
    [No Abstract]   [Full Text] [Related]  

  • 15. The proteasome: a suitable antineoplastic target.
    Adams J
    Nat Rev Cancer; 2004 May; 4(5):349-60. PubMed ID: 15122206
    [No Abstract]   [Full Text] [Related]  

  • 16. American Society of Hematology - 45th annual meeting and exposition.
    Pinilla J
    IDrugs; 2004 Feb; 7(2):128-32. PubMed ID: 15057655
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in gene therapy and alternative therapies in nonmalignant hematology from the 2016 American Society of Hematology meeting.
    Clin Adv Hematol Oncol; 2017 Feb; 15(2):113-116. PubMed ID: 28398280
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer research. Taking garbage in, tossing cancer out?
    Garber K
    Science; 2002 Jan; 295(5555):612-3. PubMed ID: 11809952
    [No Abstract]   [Full Text] [Related]  

  • 19. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
    Mitra AP
    IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
    [No Abstract]   [Full Text] [Related]  

  • 20. Marching against blood diseases: a report from the 51st Annual Meeting of the American Society of Hematology (December 5-8, 2009 - New Orleans, Lousiana, USA).
    Rabasseda X
    Drugs Today (Barc); 2010 Mar; 46(3):195-230. PubMed ID: 20467593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.